Nestlé will use its scientific know-how and applications expertise to validate the efficacy of these new discoveries within the target applications.
Irish biotechnology company Nuritas has collaborated with Nestlé to research bioactive peptide networks within specific target areas.
In order to achieve the common goal, Nuritas will deploy its technology platform, which uses artificial intelligence and DNA analysis to predict, unlock, and validate highly efficacious peptides, exclusively from natural food sources.
Nestlé will use its scientific know-how and applications expertise to validate the efficacy of these new discoveries within the target applications.
Headed by ex-Nestle regional President Emmet Browne, Nuritas was recently given a €3 million EU grant to continue working on an unnamed peptide for diabetes prevention, and has entered into a collaboration with the international ingredient giant BASF for the discovery and commercialisation of functional peptides.
